Growth Metrics

INVO Fertility (IVF) Shares Outstanding (Diluted Average) (2011 - 2025)

INVO Fertility (IVF) reported Shares Outstanding (Diluted Average) of $1.4 million for Q3 2025, up 1216.23% year-over-year from $107949.0 in Q3 2024, and up 375.02% on a QoQ basis from $299114.0 in Q2 2025.

INVO Fertility (IVF) has 15 years of Shares Outstanding (Diluted Average) data on file, last reported at $1.4 million in Q3 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 1216.23% year-over-year to $1.4 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1.4 million (up 1216.23% YoY) and the FY2024 annual result came in at $309539.0, up 159.54% from the prior year.
  • Shares Outstanding (Diluted Average) advanced to $1.4 million in Q3 2025 per IVF's latest filing, from $299114.0 in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $12.1 million in Q1 2022 and bottomed at $85360.0 in Q2 2024.
  • The 5-year median for Shares Outstanding (Diluted Average) is $622507.0 (2023), against an average of $3.3 million.
  • The widest annual swing landed in 2023, when Shares Outstanding (Diluted Average) plunged 94.83%; it then surged 1216.23% in 2025.
  • Tracing IVF's Shares Outstanding (Diluted Average) over 5 years: stood at $10.6 million in 2021, then plunged by 94.3% to $606130.0 in 2022, then plunged by 80.32% to $119264.0 in 2023, then jumped by 159.54% to $309539.0 in 2024, then jumped by 359.02% to $1.4 million in 2025.
  • Per Business Quant, the three latest IVF Shares Outstanding (Diluted Average) figures stand at $1.4 million (Q3 2025), $299114.0 (Q2 2025), and $1.4 million (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.75 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 386.50 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.29 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.50 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 580.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 393.60 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 457.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 INVO Fertility 5.12 Mn 4.76 Mn 629,345.00 1.42 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 1.42 Mn
Jun 30, 2025 299,114.00
Mar 31, 2025 1.39 Mn
Dec 31, 2024 309,539.00
Sep 30, 2024 107,949.00
Jun 30, 2024 85,360.00
Mar 31, 2024 211,329.00
Dec 31, 2023 119,264.00
Sep 30, 2023 1.78 Mn
Jun 30, 2023 732,255.00
Mar 31, 2023 622,507.00
Dec 31, 2022 606,130.00
Sep 30, 2022 605,356.00
Jun 30, 2022 604,123.00
Mar 31, 2022 12.05 Mn
Dec 31, 2021 10.63 Mn
Sep 30, 2021 10.46 Mn
Jun 30, 2021 10.44 Mn
Mar 31, 2021 9.89 Mn
Dec 31, 2020 5.49 Mn
Sep 30, 2020 4.93 Mn
Jun 30, 2020 4.93 Mn
Mar 31, 2020 4.92 Mn
Dec 31, 2019 4.85 Mn
Sep 30, 2019 4.86 Mn
Jun 30, 2019 7.74 Mn
Mar 31, 2019 154.10 Mn
Dec 31, 2018 147.33 Mn
Sep 30, 2018 147.45 Mn
Jun 30, 2018 147.32 Mn
Mar 31, 2018 143.34 Mn
Dec 31, 2017 141.31 Mn
Sep 30, 2017 141.38 Mn
Jun 30, 2017 141.28 Mn
Mar 31, 2017 140.75 Mn
Dec 31, 2016 139.19 Mn
Sep 30, 2016 140.60 Mn
Jun 30, 2016 138.44 Mn
Dec 31, 2015 128.57 Mn
Sep 30, 2015 133.24 Mn
Jun 30, 2015 125.58 Mn
Mar 31, 2015 119.79 Mn
Dec 31, 2014 112.67 Mn
Sep 30, 2014 111.40 Mn
Jun 30, 2014 111.40 Mn
Mar 31, 2014 111.40 Mn
Dec 31, 2013 107.06 Mn
Sep 30, 2013 105.91 Mn
Jun 30, 2013 107.24 Mn
Mar 31, 2013 104.04 Mn
Dec 31, 2012 89.06 Mn
Sep 30, 2012 91.16 Mn
Jun 30, 2012 87.92 Mn
Mar 31, 2012 85.41 Mn
Dec 31, 2011 78.66 Mn
Sep 30, 2011 78.64 Mn
Jun 30, 2011 77.21 Mn